LBRY Block Explorer

LBRY Claims • inflammatorydiseases_therapeuticdrug_treatinflammatory_signal_called_Tozorakimab_signalactivates_RTCLTV_shorts

fb3808cb0e29fa37e0ac31fc505c597943af64d3

Published By
Created On
23 Sep 2023 22:18:59 UTC
Transaction ID
Cost
Safe for Work
Free
Yes
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2... | RTCL.TV
### Keywords ###
#inflammatorydiseases #therapeuticdrug #treatinflammatory #signal #called #Tozorakimab #signalactivates #RTCLTV #shorts

### Article Attribution ###
Title: Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
Authors: Elizabeth England, D. Gareth Rees, Ian Christopher Scott, Sara Carmen, Denice T. Y. Chan, Catherine E. Chaillan Huntington, Kirsty F. Houslay, Teodor Erngren, Mark Penney, Jayesh B. Majithiya, Laura Rapley, Dorothy A. Sims, Claire Hollins, Elizabeth C. Hinchy, Martin D. Strain, Benjamin P. Kemp, Dominic J. Corkill, Richard D. May, Katherine A. Vousden, Robin J. Butler, Tomas Mustelin, Tristan J. Vaughan, David C. Lowe, Caroline Colley ,and E. Suzanne Cohen
Publisher: Nature Portfolio
DOI: 10.1038/s41598-023-36642-y
DOAJ URL: https://doaj.org/article/4d1e1f2da3f148aa85e1df6a32f0ef69
Source URL: https://doi.org/10.1038/s41598-023-36642-y



### Image Attribution ###
We used stable diffusion to programmatically generate the background images.
Viewer discretion is advised.

### Channels ###
YouTube Channel: https://www.youtube.com/@medicinertcltv
Odysee Channel: https://odysee.com/@medicine_rtcl_tv

### Video Timestamps ###
0:00:00 - Summary
0:00:47 - Title
0:00:53 - End
Author
Content Type
Unspecified
video/mp4
Language
Unspecified
Open in LBRY

More from the publisher

Controlling
VIDEO
A CON
Controlling
VIDEO
LIMIT
Controlling
VIDEO
IN VI
Controlling
VIDEO
LARVA
Controlling
VIDEO
MENTA
Controlling
VIDEO
FODDE
Controlling
VIDEO
MULTI
Controlling
VIDEO
EVOLV
Controlling
VIDEO
CHANG